Chronic myeloid leukemia (CML) with e1a2 BCR-ABL fusion transcript type: Analysis of characteristics, outcomes, and prognostic significance

被引：0
|
作者：
Verma, D. [1 ]
Kantarjian, H. [1 ]
Jones, D. [1 ]
Borthakur, G. [1 ]
Garcia-Manero, G. [1 ]
Thomas, D. A. [1 ]
Verstovsek, S. [1 ]
Rios, M. [1 ]
Cortes, J. [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7030
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Can absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid leukemia from chronic myelomonocytic leukemia?
    Langabeer, Stephen E.
    Bhreathnach, Una
    Cahill, Mary R.
    Elhassadi, Ezzat
    Loingsigh, Sorcha Ni
    Conneally, Eibhlin
    Enright, Helen
    BLOOD CELLS MOLECULES AND DISEASES, 2021, 87
  • [42] Chronic Myeloid Leukemia (CML) Patients With Atypical e1a2 P190 BCR-ABL Translocation Show a Poor Response To Therapy With Tyrosine Kinase Inhibitors (TKI)
    Montoriol-Sabate, Carme
    Martinez-Laperche, Carolina
    Jimenez-Gamiz, P.
    Collado, Rosa
    Minguela-Puras, Alfredo
    Pinan-Frances, M. A.
    Bellosillo, B.
    Martinez-Lopez, Joaquin
    Gonzalez, Marcos
    Larrayoz, Maria Jose
    Calasanz, MaJose
    Gomez-Casares, Maria Teresa
    Gonzalez-Brito, G.
    Soler, Gloria
    Roman, Jose
    Jimenez-Velasco, A.
    Buno, Ismael
    BLOOD, 2013, 122 (21)
  • [43] BCR-ABL Fusion Transcript Do Not Significantly Influence the Outcome of Chronic Myeloid Leukemia Patients In Early Chronic Phase Treated with Imatinib Mesylate: a GIMEMA CML WP Analysis
    Cagtagnetti, Fausto
    Gugliotta, Gabriele
    Palandri, Francesca
    Breccia, Massimo
    Specchia, Giorgina
    Abruzzese, Elisabetta
    Intermesoli, Tamara
    Capucci, Adele
    Martino, Bruno
    Stagno, Fabio
    Pregno, Patrizia
    Amabile, Marilina
    Soyerini, Simona
    Testoni, Nicoletta
    Alimena, Giuliana
    Martinelli, Giovanni
    Pane, Fabrizio
    Saglio, Giuselipe
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2010, 116 (21) : 526 - 526
  • [44] BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia
    Wilson, G
    Frost, L
    Goodeve, A
    Vandenberghe, E
    Peake, I
    Reilly, J
    BLOOD, 1997, 89 (08) : 3064 - 3064
  • [45] Frequency of BCR-ABL fusion transcripts in Serbian patients with chronic myeloid leukemia
    Todoric-Zivanovic, B.
    Strnad, M.
    Stamatovic, D.
    Tukic, L.
    Krtolica, K.
    Tatomirovic, Z.
    Djordjevic, V.
    Bogdanovic, A.
    Jankovic, G.
    Magic, Z.
    JOURNAL OF BUON, 2011, 16 (01): : 104 - 107
  • [46] Detection of BCR-ABL fusion gene in diagnosis and treatment of chronic myeloid leukemia
    Zhou, Guidan
    Xing, Shichao
    Tian, Bingru
    Chen, Youfen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (05): : 3309 - 3315
  • [47] Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia
    Yaghmaie, Marjan
    Ghaffari, Seyed H.
    Ghavamzadeh, Ardashir
    Alimoghaddam, Kamran
    Jahani, Mohammad
    Mousavi, Seyed-Asadollah
    Irvani, Masoud
    Bahar, Babak
    Bibordi, Isa
    ARCHIVES OF IRANIAN MEDICINE, 2008, 11 (03) : 247 - 251
  • [48] Molecular response to imatinib is achieved faster in chronic myeloid leukemia (CML) patients harboring the e14a2 BCR-ABL fusion transcript compared to those harboring e13a2
    Hanfstein, B.
    Erben, P.
    Agrawal, M.
    Schnittger, S.
    Ernst, T.
    Schenk, T.
    Hofmann, W-K
    Hehlmann, R.
    Hochhaus, A.
    Mueller, M. C.
    ONKOLOGIE, 2010, 33 : 145 - 145
  • [49] Influence of BCR-ABL Transcript Type on Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
    Barbosa Pagnano, Katia Borgia
    Miranda, Eliana Cristina
    Delamain, Marcia Torresan
    Duarte, Gislaine Oliveira
    de Paula, Erich Vinicius
    Lorand-Metze, Irene
    de Souza, Carmino Antonio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (11): : 728 - 733
  • [50] BCR-ABL transcript variant's significance in chronic myeloid leukemia in chronic phase: Institutional experience from a developing country
    Prasad, S. K.
    Chennamaneni, R.
    Stalin, B.
    Konatam, M. L.
    Gundeti, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 445 - 445
12345